Cell therapy aims to treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body. With cell therapy, cells are cultivated or modified outside the body before being injected into the patient. Gene therapy aims to treat diseases by replacing, inactivating or introducing genes into cells – either inside the body (in vivo) or outside of the body (ex vivo). The global cell and gene therapy clinical trial market is likely to register a CAGR of over 12.3% 随着美元的增量增长 7.2 预测期内 10 亿 2023-2029.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global cell and gene therapy clinical trial market. 它提供了对市场的定量分析，使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the phase, 指示, 和地区. The global market for cell and gene therapy clinical trial can be segmented by phase: 第一阶段, 第二阶段, 第三阶段, 第四阶段. The phase II segment was the largest contributor to the global cell and gene therapy clinical trial market in 2022. Cell and gene therapy clinical trial market is further segmented by indication: cardiology, CNS diseases, endocrine, metabolic and genetic, gastroenterology, hematology, immunology and inflammation, musculoskeletal, 肿瘤学, ophthalmology, 其他的. 据研究, the oncology segment had the largest share in the global cell and gene therapy clinical trial market. 根据地区, the cell and gene therapy clinical trial market is segmented into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. 北美地区占据最大的收入份额 2022.

市场细分
By phase: 第一阶段, 第二阶段, 第三阶段, 第四阶段
按指示: cardiology, CNS diseases, endocrine, metabolic and genetic, gastroenterology, hematology, immunology and inflammation, musculoskeletal, 肿瘤学, ophthalmology, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report also provides analysis of the key companies of the industry and their detailed company profiles including Charles River Laboratories International, 公司, ICON plc, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), Medpace Holdings, 公司, Novotech Health Holdings Ltd., PAREXEL International Corporation, PPD, 公司, PSI CRO AG, Syneos Health, 公司, Veristat, 有限责任公司, WuXi AppTec, 公司, 除其他外. 在这份报告中, 全面分析关键参与者及其策略，以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global cell and gene therapy clinical trial market.
• To classify and forecast the global cell and gene therapy clinical trial market based on phase, 指示, 地区.
• To identify drivers and challenges for the global cell and gene therapy clinical trial market.
• 检查竞争性发展，例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global cell and gene therapy clinical trial market.
• To identify and analyze the profile of leading players operating in the global cell and gene therapy clinical trial market.

为什么选择这份报告
• Gain a reliable outlook of the global cell and gene therapy clinical trial market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.